Hyperhomocysteinemia and Neurologic Disorders: a Review

被引:96
作者
Ansari, Ramin [1 ]
Mahta, Ali [1 ]
Matlack, Eric [2 ]
Luo, Jin Jun [1 ]
机构
[1] Temple Univ, Sch Med, Dept Neurol, Philadelphia, PA USA
[2] New York Presbyterian Hosp, Weill Cornell Med Ctr, Dept Pediat, New York, NY USA
来源
JOURNAL OF CLINICAL NEUROLOGY | 2014年 / 10卷 / 04期
关键词
hyperhomocysteinemia; neurologic disorders; pregnancy; PLASMA HOMOCYSTEINE LEVELS; MILD COGNITIVE IMPAIRMENT; FOLIC-ACID SUPPLEMENTATION; CONGENITAL HEART-DEFECTS; PARKINSONS-DISEASE; REDUCTASE GENE; METHYLENETETRAHYDROFOLATE REDUCTASE; MULTIPLE-SCLEROSIS; ALZHEIMERS-DISEASE; VITAMINS B-12;
D O I
10.3988/jcn.2014.10.4.281
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
Homocysteine (Hey) is a sulfur-containing amino acid that is generated during methionine metabolism. It has a physiologic role in DNA metabolism via methylation, a process governed by the presentation of folate, and vitamins B6 and B12. Physiologic Hcy levels are determined primarily by dietary intake and vitamin status. Elevated plasma levels of Hcy (eHcy) can be caused by deficiency of either vitamin B12 or folate, or a combination thereof. Certain genetic factors also cause eHcy, such as C667T substitution of the gene encoding methylenetetrahydrofolate reductase. eHcy has been observed in several medical conditions, such as cardiovascular disorders, atherosclerosis, myocardial infarction, stroke, minimal cognitive impairment, dementia, Parkinson's disease, multiple sclerosis, epilepsy, and eclampsia. There is evidence from laboratory and clinical studies that Hey, and especially eHcy, exerts direct toxic effects on both the vascular and nervous systems. This article provides a review of the current literature on the possible roles of eHcy relevant to various neurologic disorders.
引用
收藏
页码:281 / 288
页数:8
相关论文
共 97 条
[1]   Pathogenesis-Targeted, Disease-Modifying Therapies in Parkinson Disease [J].
AlDakheel, Amaal ;
Kalia, Lorraine V. ;
Lang, Anthony E. .
NEUROTHERAPEUTICS, 2014, 11 (01) :6-23
[2]   Relation between homocysteinaemia and diabetic neuropathy in patients with Type 2 diabetes mellitus [J].
Ambrosch, A ;
Dierkes, J ;
Lobmann, R ;
Kühne, W ;
König, W ;
Luley, C ;
Lehnert, H .
DIABETIC MEDICINE, 2001, 18 (03) :185-192
[3]  
Annerbo Sylvia, 2006, Am J Alzheimers Dis Other Demen, V21, P182, DOI 10.1177/1533317506289282
[4]  
[Anonymous], 1991, Lancet, V338, P131, DOI 10.1016/0140-6736(91)90133-A
[5]  
Athyros VG., 2010, OPEN CLIN CHEM J, V3, P19
[6]   Folic Acid Supplementation and Cardiovascular Disease: The State of the Art [J].
Bazzano, Lydia A. .
AMERICAN JOURNAL OF THE MEDICAL SCIENCES, 2009, 338 (01) :48-49
[7]   Antiepileptic drugs and MTHFR Polymorphisms influence hyper-homocysteinemia recurrence in epileptic patients [J].
Belcastro, Vincenzo ;
Gorgone, Gaetano ;
Italiano, Domenico ;
Oteri, Giancarla ;
Caccamo, Daniela ;
Pisani, Laura Rosa ;
Striano, Pasquale ;
Striano, Salvatore ;
Lentile, Riccardo ;
Pisani, Francesco .
EPILEPSIA, 2007, 48 (10) :1990-1994
[8]   Hyperhomocysteinemia in epileptic patients on new antiepileptic drugs [J].
Belcastro, Vincenzo ;
Striano, Pasquale ;
Gorgone, Gaetano ;
Costa, Cinzia ;
Ciampa, Clotilde ;
Caccamo, Daniela ;
Pisani, Laura R. ;
Oteri, Giancarla ;
Marciani, Maria G. ;
Aguglia, Umberto ;
Striano, Salvatore ;
Lentile, Riccardo ;
Calabresi, Paolo ;
Pisani, Francesco .
EPILEPSIA, 2010, 51 (02) :274-279
[9]  
Bialecka M, 2009, NEUROL NEUROCHIR POL, V43, P272
[10]   Conversion from cognitive health to mild cognitive impairment and Alzheimer's disease: Prediction by plasma amyloid beta 42, medial temporal lobe atrophy and homocysteine [J].
Blasko, Imrich ;
Jellinger, Kurt ;
Kemmler, Georg ;
Krampla, Wolfgang ;
Jungwirth, Susanne ;
Wichart, Ildigo ;
Tragl, Karl Heinz ;
Fischer, Peter .
NEUROBIOLOGY OF AGING, 2008, 29 (01) :1-11